Department of General Surgery, Division of Transplantation and Liver Surgery, Chang Gung Memorial Hospital Linkou Medical Center, Linkou, Taiwan.
Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.
The choice between minor versus major resection or anatomic versus nonantatomic resection for small (<5 cm) solitary hepatocellular carcinoma (HCC) in patients with cirrhosis is controversial. The aim of our study was to evaluate the long-term disease-free survival (DFS) and overall survival (OS) after minor or major hepatic resection for small solitary HCC in cirrhotic patients.
Between January 1983 and December 2002, patients with solitary HCC of < or = 5 cm in size who had histologically proven liver cirrhosis and microscopically tumor-free margin were included. These selected patients underwent either minor (< or = 2 segments) or major (> or = 3 segments) hepatectomy.
In 373 patients, 259 underwent minor and 114 underwent major hepatectomy. Patients in the minor resection group had more severe underlying liver disease (P = .005). Therefore, only 29.3% received anatomic resection in the minor resection group in comparison with 72.8% in the major hepatectomy group (P = .0001). No difference was found in postoperative morbidity (P = .105), mortality (P =.222), intrahepatic recurrence (P = .742), and 5-year DFS and OS (31.6% vs 31.8%, P = .932 and 50.7% vs 44.0%, P = .114) in both groups. The type of operative resection was not found to be a significant factor affecting survival in univariate analysis, but the preoperative liver function (alanine aminotransferase [AST] or alanine aminotransferase [ALT], serum albumin, or Child-Pugh status), tumor characteristics (alpha-feto protein, size, and presence of daughter nodules), and blood transfusion were found to be independent factors that affect the DFS and OS in a multivariate analysis.
The severity of cirrhosis and tumor characteristics depicts long-term survival rather than the type of resection in HCC.
对于肝硬化患者的小(<5 厘米)单发肝细胞癌(HCC),选择小范围肝切除术还是大范围肝切除术(解剖性肝切除术或非解剖性肝切除术)存在争议。我们的研究目的是评估小的单发 HCC 肝硬化患者接受小范围肝切除术或大范围肝切除术的长期无病生存率(DFS)和总生存率(OS)。
1983 年 1 月至 2002 年 12 月,我们纳入了经组织学证实为肝硬化且肿瘤切缘镜下无肿瘤的单个 HCC 大小≤5cm 的患者。这些患者选择接受小范围肝切除术(<或=2 个肝段)或大范围肝切除术(>或=3 个肝段)。
在 373 名患者中,259 名接受小范围肝切除术,114 名接受大范围肝切除术。小范围肝切除术组患者的基础肝脏疾病更严重(P=0.005)。因此,小范围肝切除术组仅 29.3%的患者接受解剖性肝切除术,而大范围肝切除术组有 72.8%的患者接受解剖性肝切除术(P=0.0001)。两组患者术后发病率(P=0.105)、死亡率(P=0.222)、肝内复发(P=0.742)以及 5 年 DFS 和 OS(31.6%比 31.8%,P=0.932;50.7%比 44.0%,P=0.114)均无差异。单因素分析未发现手术切除类型是影响生存的显著因素,但术前肝功能(丙氨酸氨基转移酶[AST]或天冬氨酸氨基转移酶[ALT]、血清白蛋白或 Child-Pugh 分级)、肿瘤特征(甲胎蛋白、大小和子灶结节的存在)和输血是影响多因素分析中 DFS 和 OS 的独立因素。
肝硬化严重程度和肿瘤特征比 HCC 的切除类型更能预测长期生存。